Abstract:
Background
Cervical cancer screening offers protective benefits and is associated with a reduction in the incidence
of invasive cervical cancer and cervical cancer mortality. Despite the strong evidence that cervical
cancer screening results in decreased mortality from this disease, its utilization remains low.
Objective: This study was conducted to assess cervical cancer screening service utilization and
associated factors among HIV positive women at Burayu health center, BurayuTown, Oromia, Ethiopia,
2022.
Methods: facility based cross sectional study was conducted from December, 2021 to February, 2022.
A total of 234 women from HIV positive women come to the Health Center were selected by
systematic random sampling method. Data were collected by interviewer administered and from
medical record review entered to Epi data version 3.1 and then exported to SPSS version 23 for
analysis. Bi variable and multivariable logistic regressions were used to identify factors associated with
outcome variable. The strength of association between independent variables and dependent was
measured using adjusted odds ratio and 95% confidence interval and P-values below 0.05 were used as
a cut of point for multivariable logistic regression model.
Results: The magnitude of cervical cancer screening is found to be 69.7% CI of 95%, 64.1- 75.2).
WHO clinical stage one (AOR=7.49:95% CI, 1.13-49.55), knowing availability of cervical cancer
screening service (AOR=24.54,95% CI ,4.25,141.67) , years of enrollment for care and treatment five
to nine year [AOR=3.82 (95% CI (1.47,9.94).have statistically significance with cervical cancer
screening among HIV positive women currently on ART follow up.
Conclusion and Recommendation:
Even if utilization of cervical cancer screening among HIV positive women in the study area was
remained less from recommended coverage of the target group by the national guideline of Ethiopia
(80%).it is promising when compared to previous studies conducted in different areas in Ethiopia.
Health centers better to work to increase cervical cancer screening through linkage to screening clinics
and counseling regardless of their clinical stage as base line clinical care for all HIV positive women.
